RxDoctor Payments Data

Ryan Jones, MD

Family Medicine · Sarasota, FLNPI 1861019010

Payments from drug & device makers

$925in general payments, 2019–2025

Across 38 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$162
  • Bayer$159
  • Amgen$92
  • Novo Nordisk$86
  • Pfizer$64
  • VYNE Pharmaceuticals Inc.$55
  • plus $307 from 11 others

What the payments were for

  • Food & beverage$87995%
  • Education$465%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$925 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$52,090
Medicare patients
172
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide28$31,115
EliquisApixaban18$10,502
Tamsulosin Hcl39$1,008
Atorvastatin Calcium172$907
Acetaminophen-CodeineAcetaminophen With Codeine11$808
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide19$698
Rosuvastatin Calcium72$636
Pantoprazole Sodium33$570
Albuterol Sulfate HfaAlbuterol Sulfate11$552
Oxybutynin Chloride ErOxybutynin Chloride26$453
Metoprolol Succinate30$400
Levothyroxine Sodium73$393
Omeprazole19$333
Gabapentin28$320
Lisinopril47$290

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$162$31,11528 claims
PfizerEliquis$64$10,50218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →